Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Screening of Phenanthroquinolizidine Alkaloid Derivatives for Inducing Cell Death of L1210 Leukemia Cells with Negative and Positive P-glycoprotein Expression.

Kubíčková J, Elefantová K, Pavlikova L, Cagala M, Šereš M, Šafář P, Marchalín Š, Ďurišová K, Boháčová V, Sulova Z, Lakatoš B, Breier A, Olejníková P.

Molecules. 2019 Jun 5;24(11). pii: E2127. doi: 10.3390/molecules24112127.

2.

Detection of the Mitochondrial Membrane Potential by the Cationic Dye JC-1 in L1210 Cells with Massive Overexpression of the Plasma Membrane ABCB1 Drug Transporter.

Elefantova K, Lakatos B, Kubickova J, Sulova Z, Breier A.

Int J Mol Sci. 2018 Jul 7;19(7). pii: E1985. doi: 10.3390/ijms19071985.

3.

Overexpression of the ABCB1 drug transporter in acute myeloid leukemia cells is associated with downregulation of latrophilin-1.

Kocibalova Z, Guzyova M, Imrichova D, Sulova Z, Breier A.

Gen Physiol Biophys. 2018 May;37(3):353-357. doi: 10.4149/gpb_2018008.

PMID:
29938681
4.

Triorganotin Derivatives Induce Cell Death Effects on L1210 Leukemia Cells at Submicromolar Concentrations Independently of P-glycoprotein Expression.

Bohacova V, Seres M, Pavlikova L, Kontar S, Cagala M, Bobal P, Otevrel J, Brtko J, Sulova Z, Breier A.

Molecules. 2018 May 1;23(5). pii: E1053. doi: 10.3390/molecules23051053.

5.

Interplay between P-Glycoprotein Expression and Resistance to Endoplasmic Reticulum Stressors.

Hano M, Tomášová L, Šereš M, Pavlíková L, Breier A, Sulová Z.

Molecules. 2018 Feb 6;23(2). pii: E337. doi: 10.3390/molecules23020337. Review.

6.

L1210 Cells Overexpressing ABCB1 Drug Transporters Are Resistant to Inhibitors of the N- and O-glycosylation of Proteins.

Pavlikova L, Seres M, Hano M, Bohacova V, Sevcikova I, Kyca T, Breier A, Sulova Z.

Molecules. 2017 Jul 3;22(7). pii: E1104. doi: 10.3390/molecules22071104.

7.

The expression of P-gp in leukemia cells is associated with cross-resistance to protein N-glycosylation inhibitor tunicamycin.

Pavlikova L, Seres M, Imrichova D, Hano M, Rusnak A, Zamorova M, Katrlik J, Breier A, Sulova Z.

Gen Physiol Biophys. 2016 Oct;35(4):497-510.

PMID:
27763330
8.

The expression of P-glycoprotein in leukemia cells is associated with the upregulated expression of nestin, a class 6 filament protein.

Coculova M, Imrichova D, Seres M, Messingerova L, Bohacova V, Sulova Z, Breier A.

Leuk Res. 2016 Sep;48:32-9. doi: 10.1016/j.leukres.2016.05.021. Epub 2016 Jul 21.

PMID:
27479651
9.

A decrease in cellular microRNA-27a content is involved in azacytidine-induced P-glycoprotein expression in SKM-1 cells.

Messingerova L, Imrichova D, Kavcova H, Seres M, Sulova Z, Breier A.

Toxicol In Vitro. 2016 Oct;36:81-88. doi: 10.1016/j.tiv.2016.07.002. Epub 2016 Jul 7.

PMID:
27396688
10.

Molecular changes induced by repeated restraint stress in the heart: the effect of oxytocin receptor antagonist atosiban.

Bartekova M, Barancik M, Pokusa M, Prokopova B, Radosinska J, Rusnak A, Breier A, Jezova D.

Can J Physiol Pharmacol. 2015 Sep;93(9):827-34. doi: 10.1139/cjpp-2015-0096. Epub 2015 Jun 24.

PMID:
26323039
11.

Acute myeloid leukemia cells MOLM-13 and SKM-1 established for resistance by azacytidine are crossresistant to P-glycoprotein substrates.

Messingerova L, Imrichova D, Kavcova H, Turakova K, Breier A, Sulova Z.

Toxicol In Vitro. 2015 Oct;29(7):1405-15. doi: 10.1016/j.tiv.2015.05.011. Epub 2015 May 22.

PMID:
26009263
12.

Lenalidomide treatment induced the normalization of marker protein levels in blood plasma of patients with 5q-myelodysplastic syndrome.

Messingerová L, Jonášová A, Barančik M, Poleková L, Šereš M, Gibalová L, Breier A, Sulová Z.

Gen Physiol Biophys. 2015 Oct;34(4):399-406.

PMID:
26001289
13.

Reduced UDP-glucose Levels Are Associated with P-glycoprotein Over-expression in L1210 Cells and Limit Glucosylceramide Synthase Activity.

Turáková K, Pavlíková L, Messingerová L, Lakatoš B, Breier A, Sulová Z.

Anticancer Res. 2015 May;35(5):2627-34.

PMID:
25964538
14.

Vincristine-induced expression of P-glycoprotein in MOLM-13 and SKM-1 acute myeloid leukemia cell lines is associated with coexpression of nestin transcript.

Imrichova D, Coculova M, Messingerova L, Sulova Z, Breier A.

Gen Physiol Biophys. 2014;33(4):425-31. doi: 10.4149/gpb_2014015. Epub 2014 Jun 26.

PMID:
24968412
15.

Detection of glycomic alterations induced by overexpression of p-glycoprotein on the surfaces of L1210 cells using sialic acid binding lectins.

Bubencíkova T, Cholujová D, Messingerová L, Mislovicova D, Seres M, Breier A, Sulova Z.

Int J Mol Sci. 2012 Nov 16;13(11):15177-92. doi: 10.3390/ijms131115177.

16.

New insight into p-glycoprotein as a drug target.

Breier A, Gibalova L, Seres M, Barancik M, Sulova Z.

Anticancer Agents Med Chem. 2013 Jan;13(1):159-70. Review.

PMID:
22931413
17.

Potentiation of anticancer drugs: effects of pentoxifylline on neoplastic cells.

Barancik M, Bohacova V, Gibalova L, Sedlak J, Sulova Z, Breier A.

Int J Mol Sci. 2012;13(1):369-82. doi: 10.3390/ijms13010369. Epub 2011 Dec 28.

18.

P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation.

Gibalová L, Sereš M, Rusnák A, Ditte P, Labudová M, Uhrík B, Pastorek J, Sedlák J, Breier A, Sulová Z.

Toxicol In Vitro. 2012 Apr;26(3):435-44. doi: 10.1016/j.tiv.2012.01.014. Epub 2012 Jan 17.

PMID:
22269388
19.

Tunicamycin depresses P-glycoprotein glycosylation without an effect on its membrane localization and drug efflux activity in L1210 cells.

Sereš M, Cholujová D, Bubenčíkova T, Breier A, Sulová Z.

Int J Mol Sci. 2011;12(11):7772-84. doi: 10.3390/ijms12117772. Epub 2011 Nov 10.

20.

α2 integrin as regulator of metastatic potential.

Barancik M, Breier A.

Acta Pharmacol Sin. 2011 Mar;32(3):279. doi: 10.1038/aps.2011.12. No abstract available.

Supplemental Content

Loading ...
Support Center